Pharma and Biotech
By Sean Farrell
Date: Thursday 15 Jul 2021
(Sharecast News) - Nuformix's annual loss widened as revenue fell and the pharmaceutical company spent to development its treatments.
By Sean Farrell
Date: Wednesday 10 Feb 2021
(Sharecast News) - Chris Blackwell has quit as Nuformix's chairman a year after taking the job at the drug development company.
By Josh White
Date: Thursday 18 Jul 2019
(Sharecast News) - Nuformix reported total revenue of £0.61m in its final results on Thursday, rising from £0.02m in the prior year, with the company swinging to a gross profit of £0.07m, from a loss of £0.19m.
Currency | UK Pounds |
Share Price | 0.048p |
Change Today | 0.003p |
% Change | -5.00 % |
52 Week High | 0.40p |
52 Week Low | 0.046p |
Volume | 13,310,496 |
Shares Issued | 1,419.31m |
Market Cap | £0.67m |
Beta | 0.07 |
RiskGrade | 322 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:05 | 223,350 @ 0.049p |
11:00 | 1,076,902 @ 0.047p |
09:51 | 2,010,244 @ 0.049p |
09:20 | 10,000,000 @ 0.046p |
You are here: research